Showing 1 - 6 results of 6 for search 'Kavya Ramkumar', query time: 0.03s Refine Results
  1. 1
    Clinal variation as a tool to understand climate change

    Clinal variation as a tool to understand climate change by Harshad Vijay Mayekar, Durga Kavya Ramkumar, Divita Garg, Abhishek Nair, Ashwin Khandelwal, Kavya Joshi, Subhash Rajpurohit

    Published 2022-10-01
    Get full text
    Article
  2. 2
    Design, Synthesis and Structure-activity Studies of Rhodanine Derivatives as HIV-1 Integrase Inhibitors

    Design, Synthesis and Structure-activity Studies of Rhodanine Derivatives as HIV-1 Integrase Inhibitors by Kavya Ramkumar, Vladimir N. Yarovenko, Alexandra S. Nikitina, Igor V. Zavarzin, Mikhail M. Krayushkin, Leonid V. Kovalenko, Adrian Esqueda, Srinivas Odde, Nouri Neamati

    Published 2010-06-01
    Get full text
    Article
  3. 3
    900 Depleting non-canonical, cell-intrinsic PD-L1 signals induces synthetic lethality to small molecule DNA damage response inhibitors in an immune independent and dependent manner

    900 Depleting non-canonical, cell-intrinsic PD-L1 signals induces synthetic lethality to small molecule DNA damage response inhibitors in an immune independent and dependent manner... by Tyler Curiel, Lauren Byers, Yilun Deng, Alvaro Padron, Harshita Gupta, Anand Kornepati, Clare Murray, Ratna Vadlamudi, Barbara Avalos, Cody Rogers, Kavya Ramkumar, Zexuan Liu, Eloise Dray, Weixing Zhao, Patrick Sung

    Published 2021-11-01
    Article
  4. 4
    Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer

    Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer by Kasey R. Cargill, C. Allison Stewart, Elizabeth M. Park, Kavya Ramkumar, Carl M. Gay, Robert J. Cardnell, Qi Wang, Lixia Diao, Li Shen, You-Hong Fan, Wai Kin Chan, Philip L. Lorenzi, Trudy G. Oliver, Jing Wang, Lauren A. Byers

    Published 2021-09-01
    Get full text
    Article
  5. 5
    Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: findings from the CAVE-Lung trial

    Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: findings from the CAVE-Lung trial by Carminia Maria Della Corte, Morena Fasano, Vincenza Ciaramella, Flora Cimmino, Robert Cardnell, Carl M. Gay, Kavya Ramkumar, Lixia Diao, Raimondo Di Liello, Giuseppe Viscardi, Vincenzo Famiglietti, Davide Ciardiello, Giulia Martini, Stefania Napolitano, Concetta Tuccillo, Teresa Troiani, Erika Martinelli, Jing Wang, Lauren Byers, Floriana Morgillo, Fortunato Ciardiello

    Published 2022-03-01
    Get full text
    Article
  6. 6
    Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC

    Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC by Carminia Maria Della Corte, Vincenza Ciaramella, Kavya Ramkumar, Giovanni Vicidomini, Alfonso Fiorelli, Valerio Nardone, Salvatore Cappabianca, Immacolata Cozzolino, Federica Zito Marino, Gaetano Di Guida, Qi Wang, Robert Cardnell, Carl Michael Gay, Davide Ciardiello, Erika Martinelli, Teresa Troiani, Giulia Martini, Stefania Napolitano, Jing Wang, Lauren Averett Byers, Fortunato Ciardiello, Floriana Morgillo

    Published 2022-11-01
    Get full text
    Article

Search Tools: